Bookmark

Add to MyYahoo RSS

Gilead Sciences News

News on Gilead Sciences (Ticker: GILD) continually updated from thousands of sources around the net.

2 hrs ago | Gizmag

Developing countries to benefit from MPP and Gilead HIV drug licensing agreement

Upon approval for use by the US, a generic version of Gilead's HIV drug TAF will be made available to low- and middle-income countries Medicine Patent Pool , a not-for-profit organization, has partnered with pharmaceutical company Gilead Sciences to produce a generic version of a new HIV treatment drug in India and China that will be distributed in ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Hepatitis, Health, Epidemic, Natural Disasters, Gadgets

11 hrs ago | Examiner.com

Is a $1,000 a pill drug really worth the cost?

Although demand for Gilead Sciences' Solvadi to treat Hepatitis-C is climbing, the fact that it costs $1,000 per 400 mg pill is raising fears that those who need it most may not be able to get it as more and more health insurance companies balk at covering it.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Hepatitis, Health

15 hrs ago | TheStreet.com

Biotech Stock Mailbag: Arrowhead, Catalyst Pharma

BOSTON -- A discussion of an experimental hepatitis B therapy kicks off this week's Biotech Stock Mailbag.

Comment?

Related Topix: Hepatitis, Medicine, Health, Intercept Pharmaceuticals, Biotech, Healthcare Industry

20 hrs ago | Seeking Alpha

3 Biotech Catalyst Stocks To Own

For companies involved in the research of drugs, no catalyst is able to trump coming out with clinical trial results.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, HIV/AIDS, Health, Viread, Tenofovir (generic), Xoma

Thu Jul 31, 2014

Seeking Alpha

Micron: Maybe It Isn't Different This Time

Micron is down over 7% today. It is down due to a bad report by Samsung and the possibility of Samsung overbuilding DRAM capacity.

Comment?

Related Topix: Semiconductors, Micron Technology, Electronics, Biotech, Medicine, Healthcare Industry

Kidney International

Contribution of the organic anion transporter OAT2 to the renal...

Correspondence: Adrian S. Ray, Gilead Sciences, 333 Lakeside Drive, Foster City, California 94404, USA.

Comment?

Related Topix: Biotech, Startups, Medicine, Gilead Sciences, CGI Pharmaceuticals, Healthcare Industry, San Mateo County, CA, Foster City, CA

The Miami Herald

Oregon Medicaid targets expensive hepatitis drug

An Oregon Medicaid committee is expected Thursday to significantly scale back access to an effective - but expensive - new drug used to treat hepatitis C. An Oregon Medicaid committee is expected Thursday to significantly scale back access to an effective - but expensive - new drug used to treat hepatitis C. The decision would allow only a narrow ... (more)

Comment?

Related Topix: Hepatitis, Medicine, Health, Biotech, Healthcare Industry

Freshnews

The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Comment?

Related Topix: Biotech, Medicine, Science / Technology, Healthcare Industry, Celgene, Financial Markets, Cancer, Health

The Washington Post

Insurers Stalled by Humana as Obamacare Raises Expectations

U.S. health insurers were dragged down by Humana Inc.'s second-quarter earning results, which matched estimates while investors had higher expectations for a boost from Obamacare.

Comment?

Related Topix: Wellpoint Health Networks, Insurance, Biotech, Medicine, Healthcare Industry, Financial Markets, Healthcare Law, Law, Business News

Forbes.com

Jitterbugging With Amazon, Google, Facebook, Apple And Microsoft

The jitterbugging action of big cap super growth properties makes me anxious. If the market is mispricing many of these names, maybe it's mispricing the valuation structure of the market, itself.

Comment?

Related Topix: Amazon, Microsoft, Startups, Financial Markets, Biotech, Medicine, Healthcare Industry, Cloud Computing, Science / Technology

Wed Jul 30, 2014

BioSpace

Gilead Sciences, Inc. Allows China/Indian Pharmas To Make Generic Version Of Novel HIV Drug

July 29, 2014 -- Gilead Sciences will allow China and Indian drugmakers to start developing generic formulations of a promising novel HIV/HBV drug, even though the drug's Phase III tests are still underway.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, HIV/AIDS, Health, Startups, Gilead Sciences, Viread, Tenofovir (generic)

AmericanBankingNews.com

Insider Selling: Gilead Sciences Director Sells 45,000 Shares of Stock

Gilead Sciences Director Nicholas G. Moore sold 45,000 shares of the company's stock in a transaction that occurred on Monday, July 28th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Myrtle Beach Online

Illinois Medicaid restricts use of hepatitis drug

After spending an estimated $16 million this fiscal year on Sovaldi, which holds promise for a cure for the liver-damaging disease, the state agency headed by Julie Hamos approved the restrictions July 10. The rules limit the drug to sicker patients and bar it for anyone with a recent history of drug or alcohol abuse.

Comment?

Related Topix: Medicaid, Health, Illinois, Illinois Government, Hepatitis, Medicine, Alcoholism, Northwestern University, Biotech, Healthcare Industry

Forbes.com

Gilead Sciences Popular Amongst Latest 13F Filers

At Holdings Channel , we have reviewed the latest batch of the 23 most recent 13-F filings for the 06/30/2014 reporting period, and noticed that Gilead Sciences, Inc. was held by 13 of these funds.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, CGI Pharmaceuticals, Financial Markets

Seeking Alpha

Gilead's Massive Undervaluation: A Pictorial Overview

Despite the rally in the stock the shares are still extremely cheap compared to other large cap biotech concerns as well as against other large cap growth plays.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, CGI Pharmaceuticals, Celgene, Regeneron Pharmaceuticals

Business Journal

Theraclone Sciences cuts HIV antibodies deal with Gilead

Theraclone Sciences Inc. of Seattle said it's made a deal with Gilead Sciences Inc. that will allow the Foster City-based biotech giant to develop and commercialize Theraclone's neutralizing HIV-antibodies for therapeutic applications in HIV.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Theraclone Sciences, Startups, Gilead Sciences

Seeking Alpha

Cramer's Mad Money - The Pause That Depresses

A Pause That Depresses: Windstream , CenturyLink , Frontier Communications , Gilead , Merck , Amgen , Twitter , Ford , Schlumberger , Aetna , Cummins , Deere , Monsanto .

Comment?

Related Topix: Hotels, MGM Mirage, Media, Cable & Satellite, Telecom, CenturyTel, Winn Dixie Stores, Retail, Grocery, Biotech, Medicine, Healthcare Industry, Frontier Communications, Amgen

Recordpub.com

Preferred hepatitis treatment is $1K

The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million.

Comment?

Related Topix: Hepatitis, Medicine, Health, Biotech, Healthcare Industry, Startups, Gilead Sciences, Health Insurance, Medicaid

Tue Jul 29, 2014

HON

Health Highlights: July 29, 2014

Despite a price tag of $1,000 per pill, and $84,000 for a full course of treatment, the new hepatitis C drug Sovaldi has quickly become the therapy of choice for patients infected with the liver-destroying virus, new data shows.

Comment?

Related Topix: US News, US Senate, Ron Wyden, Democrat, US Politics, Biotech, Medicine, Healthcare Industry

Illinoisreview

Illinois Medicaid death panel restricts who gets game-changing hepatitis drug

All posts, comments and statements made on IR are those of the authors only. Any disputes must be addressed to the writers, who are solely responsible for their posts, comments and statements.

Comment?

Related Topix: Hepatitis, Medicine, Health, Biotech, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••